newsfilter
← Latest News
GlobeNewswire·

XpresSpa Group and Ginkgo Bioworks Collaboration with the Centers for Disease Control and Prevention (CDC) COVID-19 Biosurveillance Program Expands to Include Detection of the New Omicron Variant

NEW YORK, Nov. 30, 2021 (GLOBE NEWSWIRE) -- XpresSpa Group, Inc. (NASDAQ:XSPA) ("XpresSpa" or the "Company"), a health and wellness company, today announced through a joint effort with the Centers for Disease Control and Prevention (CDC) and Ginkgo Bio